StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)

Close on Nov 17, 2026Market cap $676.84MP/E –Yield –

QuidelOrtho EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

QuidelOrtho's EV/EBITDA was 10.7× on Nov 11, 2026, against 11.0× a year earlier. Over the last 4 years it ranged from 2.3× to 21.6×, with a median of 6.4×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.7×−10.0
2025Oct 31, 202520.8×+12.5
2024Apr 30, 20248.3×−3.2
2023Dec 29, 202311.5×+5.2
2022Dec 30, 20226.3×+1.4
2021Dec 31, 20214.9×–

More QuidelOrtho figures

See a number that looks wrong?